Project Description
Updates from the CBTP Lab
The lab team at the Children’s Brain Tumor Project is working at an unprecedented pace in order to advance cures. Our team is focused on two strategic paths forward: (1) basic research toward breakthrough discoveries, and (2) translational research that will enable us to bring those discoveries to clinic.
Gift From a Child Names CBTP a Center of Excellence
Jan. 15, 2020 - The Gift from a Child Initiative, primarily funded by family-founded nonprofit The Swifty Foundation, has designated the Children’s Brain Tumor Project at Weill Cornell Medicine to serve as its fifth named “Center of Excellence” in the US.
2019 Year in Review
Dec. 31, 2019 - The team at the Children's Brain Tumor Project is proud to share some of their key accomplishments from 2019.
The CBTP Expands Precision Medicine Program
October, 2020 - Dr. Jeffrey Greenfield was recently awarded $1.08 million in support of his precision medicine initiative. The generous gift from the Patrick Bayly Marsano Foundation will enable a tremendous increase in defining individualized cancer therapies for children with rare and inoperable pediatric brain tumors.
Access to Experimental Drugs for Single-Patient Use Shows Promise in Pediatrics
June 28, 2019 - The Weill Cornell Medicine Children’s Brain Tumor Project is hopeful that single-patient use will work seamlessly in conjunction when designing patient-specific protocols based on genetic findings.
Annual Report
June 15, 2020 - Learn more about the Children's Brain Tumor Project and the impact we are making by reviewing this comprehensive annual report.
Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy
June 1, 2019 - A new research study from the CBTP lab entitled “Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy,” was published in Neuro-Oncology Advances on May 29, 2019.